Search research articles
Contact Us
Filters
Showing results (21-30 of 137) with videos related to
Page
of 14
Sort By:
The Journal of Antimicrobial Chemotherapy
|
April 1, 1997
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clots
S M Palmer, M J Rybak
American Journal of Hospital Pharmacy
|
February 15, 1994
Cefepime: part of the new generation
M J Rybak, S M Palmer
Drug Intelligence & Clinical Pharmacy
|
July 1, 1987
Ciprofloxacin
D K Terp, M J Rybak
Drug Intelligence & Clinical Pharmacy
|
March 1, 1985
Haloperidol-associated hyperthermia
D S Bach, M J Rybak
Drug Intelligence & Clinical Pharmacy
|
October 1, 1986
Monitoring vancomycin therapy
M J Rybak, S C Boike
Antimicrobial Agents and Chemotherapy
|
March 1, 1996
Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa
D M Cappelletty, M J Rybak
Antimicrobial Agents and Chemotherapy
|
June 20, 2000
In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model
R L Akins, M J Rybak
Antimicrobial Agents and Chemotherapy
|
July 1, 1995
Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model
S L Kang, M J Rybak
Antimicrobial Agents and Chemotherapy
|
March 1, 1993
Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calcium
K C Lamp, M J Rybak
The Journal of Antimicrobial Chemotherapy
|
May 1, 1997
In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus
S L Kang, M J Rybak
Page
of 14
Search research articles
Search
Showing results (21-30 of 137) with videos related to
Sort By:
Page
of 14
The Journal of Antimicrobial Chemotherapy
|
April 1, 1997
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clots
S M Palmer, M J Rybak
American Journal of Hospital Pharmacy
|
February 15, 1994
Cefepime: part of the new generation
M J Rybak, S M Palmer
Drug Intelligence & Clinical Pharmacy
|
July 1, 1987
Ciprofloxacin
D K Terp, M J Rybak
Drug Intelligence & Clinical Pharmacy
|
March 1, 1985
Haloperidol-associated hyperthermia
D S Bach, M J Rybak
Drug Intelligence & Clinical Pharmacy
|
October 1, 1986
Monitoring vancomycin therapy
M J Rybak, S C Boike
Antimicrobial Agents and Chemotherapy
|
March 1, 1996
Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa
D M Cappelletty, M J Rybak
Antimicrobial Agents and Chemotherapy
|
June 20, 2000
In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model
R L Akins, M J Rybak
Antimicrobial Agents and Chemotherapy
|
July 1, 1995
Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model
S L Kang, M J Rybak
Antimicrobial Agents and Chemotherapy
|
March 1, 1993
Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calcium
K C Lamp, M J Rybak
The Journal of Antimicrobial Chemotherapy
|
May 1, 1997
In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus
S L Kang, M J Rybak
Page
of 14